Navidea strikes radiopharmaceutical agreement with PETNet

08/22/2013 | (free registration)

A radiopharmaceutical manufacturing agreement has been solidified between PETNet Solutions and Navidea Biopharmaceuticals in support of clinical trials evaluating NAV4694. According to Navidea, the F-18 labeled PET imaging agent is being tested in patients with symptoms of cognitive disorders including Alzheimer's disease.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY